Sun, Jan 25, 2015, 12:11 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pharmacyclics Inc. Message Board

  • jgmtruth jgmtruth Apr 23, 2013 9:42 AM Flag

    Pharmacyclics PT Raised to $103.00 at Roth Capital (PCYC

    Posted by Kristian Gore on Apr 22nd, 2013 Roth Capital raised their price target on shares of Pharmacyclics (NASDAQ: PCYC) from $93.00 to $103.00 in a research note issued on Monday, Analyst Ratings Network reports. The firm currently has a “buy” rating on the stock.
    Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet downgraded shares of Pharmacyclics from a “buy” rating to a “hold” rating in a research note to investors on Thursday, April 4th. Separately, analysts at Wedbush set a $165.00 price target on shares of Pharmacyclics in a research note to investors on Wednesday, March 20th. They now have an “outperform” rating on the stock. Finally, analysts at Morgan Stanley initiated coverage on shares of Pharmacyclics in a research note to investors on Tuesday, March 19th. They set an “equal weight” rating on the stock.
    Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Pharmacyclics presently has a consensus rating of “Buy” and an average price target of $94.09.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
158.55+2.59(+1.66%)Jan 23 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.